Nufarm profits dragged down by weak Aquaterra sales

editorial staff

A drop in demand for salmon earlier this year had dented sales of Australian agricultural chemical producer Nufarm’s omega-3 canola oil product, Aquaterra.

Australian agricultural chemical company, Nufarm’s revenue and profit surged for the year to September 30 but the company says that a drop in salmon demand dented sales of its omega-3 canola oil product, Aquaterra.

Aquaterra is a non-marine source of long-chain omega-3 fatty acids produced by Nuseed, a subsidiary of Australian agrichemical giant Nufarm.

Nufarm’s revenue and profit surged for the year to September 30, but the farm chemicals group’s share price slid 7.6 per cent to AU$4.64 after management conceded the global supply chain crunch and raw material costs could pressure margins.

The company delivered net profit for the 12 months to September of AU$61.1 million, a AU$134 million turnaround from a $73.1 million loss last year.

Chief executive Greg Hunt said there were signs of recovery in the segment, “while COVID-19 disrupted salmon demand and slowed sales of our omega-3 Aquaterra product in the first half, we saw good adoption of this new technology in the second half.”

“As such, we intend to re-commence commercial plantings of omega-3 canola in calendar year 2022.”

Nufarm changed its reporting period in 2021 to better align with key sales periods and industry peers. Its fiscal year previously ended in July.


Related Articles